Articles by Angie Drakulich - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Angie Drakulich
« Previous
123456789101112
Next »

Global Healthcare on the Ground: USAID Works to Carry out President Obama's Global Health Initiative

Cultivating a productive investment environment will require partnerships with a range of stakeholders.
Dec 2, 2011
By: Angie Drakulich

Cultivating a productive investment environment will require partnerships with a range of stakeholders.

Global Healthcare on the Ground: Novartis Focuses on Treating Rare Diseases

Novartis AG and Novartis Pharmaceuticals Corporation have been focusing research efforts on rare diseases since the company was established in 1996.
Nov 2, 2011
By: Angie Drakulich

Novartis AG and Novartis Pharmaceuticals Corporation have been focusing research efforts on rare diseases since the company was established in 1996.

Is Noncompliance Just Human Nature?

Corporate management must be held accountable for quality at all levels.
Oct 2, 2011
By: Angie Drakulich

Corporate management must be held accountable for quality at all levels.

Global Healthcare on the Ground: AAPS on Why Global HealthCare is Important Now

AAPS Global Health Focus Group's Kishor M. Wasan discusses new initiatives.
Oct 2, 2011
By: Angie Drakulich

AAPS Global Health Focus Group's Kishor M. Wasan discusses new initiatives.

FDA and Department of Health Address Drug Shortages

Sep 15, 2011
By: Angie Drakulich

FDA Commissioner Margaret Hamburg and US Assistant Secretary for Health Howard Koh released a statement aimed at a stakeholder meeting being held at the US Department of Health and Human Services to address the growing issue of drug shortages in the United States.

FDA and Senate Call for Urgent Supply Chain Attention

Deborah Autor testifies before US Senate HELP committee on requested authorities to improve pharma supply chain.
Sep 14, 2011
By: Angie Drakulich

Deborah Autor testifies before US Senate HELP committee on requested authorities to improve pharma supply chain.

FDA Issues Letter to Pfizer Regarding Violative Online Marketing

Sep 8, 2011
By: Angie Drakulich

FDA's Division of Drug Marketing, Advertising, and Communication issued a letter to Pfizer's vice-president of US Regulatory Affairs regarding its online resources page for Lipitor tablets.

Atypical Actives Gain Attention

Clarifying GMPs for excipients used as actives.
Sep 1, 2011
By: Angie Drakulich

Clarifying GMPs for excipients used as actives.

USP and Brazil Partner on Public Health Education

Sep 1, 2011
By: Angie Drakulich

USP and the Brazilian National Agency of Sanitary Surveillance are teaming up to develop joint education activities for professionals involved in formulating and using pharmacopeial monograph standards in Brazil.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
100%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
0%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here